Clinical Trial Update: Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating copanlisib with rituximab and CHOP for previously untreated diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CHOP chemotherapy (cyclophosphamide, doxorubicin, vincristine, prednisone)
• Copanlisib (copanlisib)
• Rituximab (rituximab)

Snippet

Sponsor: University Hospital Muenster | Conditions: Diffuse Large B Cell Lymphoma | Phase 2 | Status: UNKNOWN